Corgenix Gains CE Mark for ReLASV® Antigen Rapid Test for Diagnosis of Lassa Fever

VHFC partner, Corgenix Medical Corporation, has developed the first commercialized diagnostic test that enables rapid diagnosis of Lassa viral hemorrhagic fever.

"This 15-minute test has the potential to completely change stye way Lassa fever is detected and treated," said Douglas Simpson, Corgenix President.

Read the full press release on the Corgenix website.

PSD to Drupal theme